Pressebereich

Actions

160511 PR VI BIOSTEMI trial EN

Actions

BIOSTEMI Trial to Establish Orsiro’s Enhanced Efficacy and Safety in Challenging Indication

Following Highly Promising Results in the BIOSCIENCE Trial, a New Study Aims to Demonstrate the Superiority of Orsiro in Treating ST-Segment Elevation Myocardial Infarction Patients






Please contact us if you require further information

${loading}